Timing note: Marsh says it will release results Tuesday, July 21, 2026, before the U.S. market opens, followed by its earnings call at 8:30 a.m. EDT. Given the stated current date, the report is scheduled for today, July 21—not tomorrow.
Marsh enters Q2 with a familiar tension: its diversified, fee-based model continues to produce resilient earnings, but falling commercial insurance and reinsurance prices are making organic growth harder to sustain.
The Street’s expectations appear achievable but leave limited room for deterioration:
| Q2 metric | Consensus / reference point |
|---|---|
| Adjusted EPS | $2.90 |
| Adjusted EPS growth | ~7% vs. $2.72 last year |
| Underlying revenue growth | ~3.6% |
| Risk & Insurance underlying growth | ~3.1% |
| Adjusted operating margin | 29.26% |
| Q2 2025 adjusted margin | 29.5% |
MRSH closed July 20 at $182.13, approximately flat year to date. The stock has recovered about 14% from its May low but remains roughly 4% below its 2026 high. That creates a fairly balanced setup: expectations have reset from earlier in the year, but investors will still want evidence that organic growth is stabilizing and that margin expansion remains intact.
Commercial insurance pricing has moved decisively into negative territory. Marsh’s Q1 index showed:
Reinsurance conditions are similarly competitive. In Q1, management described 15%–20% rate reductions for many non-loss-affected property-catastrophe programs in the U.S. and Japan. It also warned that Guy Carpenter would probably not have its best growth year in 2026.
The key offset is new business. Management reported rising new-business trends at Marsh Risk, double-digit new business in several U.S. specialties and every Guy Carpenter region, and continued strength in the middle market. Investors should therefore focus less on headline insurance rates and more on whether retention, exposure growth, new clients and additional coverage purchases are compensating for price declines.
A consolidated underlying-growth result near 4% would be reassuring. A figure near or below 3% would raise concern that the soft market is overpowering new-business momentum.
Marsh Risk generated 4% underlying growth in Q1, including:
The Q2 comparison is demanding: the business grew 5% organically in Q2 2025, including 7% internationally.
What to watch:
A 3%–4% result would demonstrate respectable cycle management. Anything materially below 3% would be disappointing.
Guy Carpenter is the most obvious pressure point. Underlying growth slowed to 2% in Q1, from 5% in the comparable period, and Q2 includes important Japanese and Florida renewal activity.
Rate reductions do not translate mechanically into equal revenue declines, but they are a clear headwind. The offsets include:
Investors should expect relatively modest growth. A return toward 3%–4% would be a positive surprise; flat or negative growth could pressure the broader organic-growth narrative.
Mercer was a relative bright spot in Q1, with 5% underlying growth:
Wealth should benefit from healthy asset levels and new mandates. Mercer reported $727 billion of assets under management at the end of Q1, up 19% year over year. Health remains a steady growth engine, while Career continues to face soft demand for U.S. project work.
The main questions are:
Another 4%–5% organic quarter from Mercer would provide an important buffer against insurance-market softness.
The former Oliver Wyman business grew 6% organically in Q1, following 6% growth for full-year 2025. Management has described its AI-focused Quotient practice as its fastest-growing capability.
Investors should watch demand in financial services, private capital, government and performance-transformation work. Consulting is more economically sensitive than insurance brokerage, but recent results suggest demand has remained solid.
Mid-single-digit growth would support the broader diversification argument.
Q1 adjusted operating income grew 8%, although consolidated adjusted margin was unchanged at 31.8%. Management has guided to:
The Street’s Q2 margin expectation of 29.26% is slightly below last year’s 29.5%. That makes the full-year commentary especially important. A modest Q2 margin decline could be tolerated if management remains confident in second-half expansion. A weak margin accompanied by less-convincing guidance would be a larger concern.
Important moving pieces include:
Several items make the $2.90 EPS hurdle more meaningful than it initially appears.
Management forecast approximately $80 million in Q2, versus $99 million a year earlier. That implies a roughly 19% year-over-year decline and is a direct drag on Risk & Insurance revenue and earnings.
Q2 interest expense was forecast at approximately $245 million, broadly unchanged from Q1 but still elevated following the McGriff financing.
Management expects a full-year adjusted tax rate of 24.5%–25.5%. Discrete tax benefits have periodically affected comparisons, so the quality of any EPS beat matters.
Marsh repurchased $750 million of stock in Q1 after buying back $2 billion during 2025. The lower share count should support per-share growth even if operating growth moderates.
Q1 GAAP earnings included a $425 million charge tied to litigation stemming from Greensill Capital’s collapse. The charge was excluded from adjusted results, and management said it represented its best estimate of the liability following court-sponsored mediation.
Investors should listen for:
This is unlikely to determine adjusted Q2 performance, but it remains relevant to GAAP earnings, cash flow and headline risk.
At the Q1 call, management expected:
Maintaining that outlook would imply confidence that softer insurance pricing can be offset by new business, consulting growth, acquisitions and productivity gains.
The market may interpret guidance as follows:
The Q2 debate is not primarily about whether Marsh can produce another EPS increase; buybacks, acquisitions and cost controls make that relatively likely. The more important issue is whether the company can hold consolidated organic growth near 4% while insurance and reinsurance prices decline.
A report featuring approximately 4% underlying growth, stable margins and unchanged full-year guidance would reinforce the view that Marsh can compound earnings across insurance cycles. A headline EPS beat driven mainly by buybacks or adjustments, alongside weaker Risk & Insurance growth, would be less convincing.
The most important numbers are therefore underlying revenue growth, Risk & Insurance organic growth and adjusted margin—followed closely by management’s confidence in second-half margin expansion.